Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Respir Med ; 227: 107657, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38718907

RESUMO

BACKGROUND: Fibrotic interstitial lung disease (fILD) is characterised primarily by impaired lung function and quality of life. The present study investigated whether oxygen therapy could improve exercise capacity among patients with fILD. METHODS: Previously published randomised controlled trials (RCTs) were surveyed. A systematic review and meta-analysis was conducted to evaluate the effectiveness of oxygen therapy in improving the exertional capacity of patients with fILD. The primary outcome was peripheral oxygen saturation (SpO2) during exercise. The effects of oxygen therapy on fatigue, dyspnoea, heart rate, and exercise duration or distance were also analysed. RESULTS: Fourteen RCTs involving 370 patients were included. Oxygen therapy improved SpO2 during exercise (mean difference, MD = 6.26 %), exercise duration (MD = 122.15 s), fatigue (standard mean difference, SMD = -0.30), and dyspnoea (MD = -0.75 Borg score units). High-flow oxygen systems tended to be more effective than low-flow systems in improving exercising SpO2, duration, fatigue, dyspnoea, and heart rate. High-flow nasal cannulas (HFNCs) yielded better outcomes regarding SpO2 and fatigue than did high-flow Venturi masks (MD = 1.60 % and MD = -1.19 Borg score units, respectively). No major adverse events were reported. CONCLUSION: The evidence from RCTs supports the short-term use of oxygen supplementation to improve SpO2, exercise capacity, fatigue, and dyspnoea among patients with fILD. Further analyses demonstrates that HFNCs yield more favourable outcomes, yet not reaching statistical significance except for improving SpO2 and fatigue. However, the long-term effects of oxygen therapy on quality of life and mortality remain unclear.


Assuntos
Dispneia , Tolerância ao Exercício , Doenças Pulmonares Intersticiais , Oxigenoterapia , Qualidade de Vida , Ensaios Clínicos Controlados Aleatórios como Assunto , Humanos , Oxigenoterapia/métodos , Tolerância ao Exercício/fisiologia , Doenças Pulmonares Intersticiais/terapia , Doenças Pulmonares Intersticiais/fisiopatologia , Dispneia/terapia , Dispneia/etiologia , Saturação de Oxigênio , Fadiga/terapia , Fadiga/etiologia , Masculino , Feminino , Frequência Cardíaca/fisiologia , Pessoa de Meia-Idade , Resultado do Tratamento , Idoso
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...